New study aims to prevent bone fractures in liver cancer patients

This study looks at whether starting denosumab early, along with a standard immunotherapy, can prevent bone problems like fractures or spinal cord compression in people with liver cancer that has spread to the bones. About 50 adults with liver cancer and bone metastases will be randomly assigned to get either early denosumab plus immunotherapy or immunotherapy alone with rescue treatment only if needed. The goal is to see which approach better delays bone complications and improves quality of life.